Advanced Head and Neck Cancer Recruiting Phase 2 Trials for Docetaxel (DB01248)

Back to Advanced Head and Neck Cancer
IndicationStatusPhase
DBCOND0076376 (Advanced Head and Neck Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05057247Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCCTreatment